A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/436 (2006.01) A61K 31/353 (2006.01) A61K 31/439 (2006.01) A61K 31/4745 (2006.01) A61K 31/56 (2006.01) A61K 45/06 (2006.01) A61P 1/00 (2006.01) A61P 11/06 (2006.01) A61P 29/00 (2006.01) A61P 37/02 (2006.01)
Patent
CA 2442969
This invention relates to methods to produce selective immunomodulation in epithelial tissues to treat epithelial inflammatory disorders. This invention provides methods for the use of pimecrolimus to treat epithelial inflammatory disorders, including asthma and inflammatory bowel disease while minimizing systemic side effects.
La présente invention concerne des procédés permettant de réaliser une immunomodulation sélective de tissus épithéliaux de façon à traiter des troubles inflammatoires épithéliaux. L'invention concerne plus particulièrement des procédés permettant d'utiliser le pimécrolimus pour traiter des troubles inflammatoires épithéliaux, y compris l'asthme et les affections inflammatoires intestinales tout en minimisant les effets secondaires systémiques.
Chibout Salah-Dine
Cordier Andre
Kehren Jeanne
Moore Henrietta Denise
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Methods for selective immunomodulation using pimecrolimus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for selective immunomodulation using pimecrolimus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for selective immunomodulation using pimecrolimus will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1415701